Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone

NCT06833411 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

178

Enrollment

OTHER

Sponsor class

Conditions

Giant Cell Arteritis (GCA)

Interventions

DRUG: Prednisone
DRUG: Prednisone

Sponsor

Insel Gruppe AG, University Hospital Bern